Suchergebnisse - "Larønningen, Siri"

PubPharm (21)

1

Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021

enthalten in: Acta oncologica (Stockholm, Sweden) | 2024

von Johansson, A. | Kønig, S. | Larønningen, S. | +15

2

Do investments in cancer registry databases and tools bring added value? NORDCAN as an example

enthalten in: Acta oncologica (Stockholm, Sweden) | 2023

von Storm, H. | Larønningen, S. | Bray, F.

3

Letter Re : Survival trends in solid cancers in the Nordic countries through 50 years: Proper referencing is necessary when using free-of-charge online cancer statistics resources, like NORDCAN

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Larønningen, S. | Storm, H.

CommentOn: Eur J Cancer. 2022 Nov;175:77-85. - PMID 36096040

4

Nordcan.R : a new tool for federated analysis and quality assurance of cancer registry data

enthalten in: Frontiers in oncology | 2023

von Larønningen, S. | Skog, A. | Engholm, G. | +13

5

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3)

enthalten in: The British journal of dermatology | 2022

von Di Carlo, V. | Stiller, C. | Eisemann, N. | +16

6

The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications : A comparison across the Nordic countries during 2020

enthalten in: International journal of cancer | 2022

von Johansson, A. | Larønningen, S. | Skovlund, C. | +15

7

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3) : analysis of individual data from 258 cancer registries in 61 countries

enthalten in: The Lancet. Child & adolescent health | 2022

von Ssenyonga, N. | Stiller, C. | Nakata, K. | +120

ErratumIn: Lancet Child Adolesc Health. 2022 Jul;6(7):e21. - PMID 35716679

8

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries ( CONCORD‐3)*

enthalten in: British Journal of Dermatology | 2022

von Di Carlo, V. | Stiller, C. | Eisemann, N. | +15

9

The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications : A comparison across the Nordic countries during 2020

enthalten in: International Journal of Cancer | 2022

von Johansson, A. | Larønningen, S. | Skovlund, C. | +15

10

The validity of cancer information on death certificates in Norway and the impact of death certificate initiated cases on cancer incidence and survival

enthalten in: Cancer epidemiology | 2021

von Møller, B. | Jerm, M. | Larønningen, S. | +4